I think its safe to assume that end points have been agreed upon. The last meeting resulted in an announcement on 07/10/2024 confirming a "constructive End of Phase 2 meeting with the FDA" had taken place. Further information was required.
So far, no such similar announcement. As they say, no news is good news.
Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-79
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.78 |
Change
0.230(1.31%) |
Mkt cap ! $2.240B | |||
| Open | High | Low | Value | Volume |
| $17.83 | $17.99 | $17.35 | $16.12M | 911.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11000 | $17.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.80 | 10070 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |